Sharps Technology, Inc. (STSSW) स्टॉक विश्लेषण

कंपनी का अवलोकन

Sharps Technology, Inc. operates as a medical device and pharmaceutical packaging entity that supplies smart-safety syringe products specifically designed for the healthcare industry, with a product focus on waste management capabilities incorporating advanced syringe technologies. The company functions within sectors and industries that have been listed as N/A in its public filings, which indicates a lack of specific industry classification data currently available for this entity. Regarding its operational scale, the company reports a market cap, annual revenue, and employee count that are all listed as N/A, suggesting that these specific aggregate metrics are either not disclosed or do not meet standard reporting thresholds in the available records. The absence of defined market cap and revenue figures in the public data limits the ability to quantify the company's precise position within the broader market, yet the provision of smart-safety syringe products suggests a specialized niche role in medical waste handling and pharmaceutical packaging solutions.

वित्तीय स्वास्थ्य

The company's financial performance over the trailing twelve months reveals a revenue of $204,120, a net income of $-270,335,424, and an EBITDA of $-13,159,940. The substantial disparity between the reported revenue of $204,120 and the net loss of $270,335,424 indicates a severe structural issue where operating costs and expenses far exceed total sales, resulting in a net loss that is disproportionately large relative to top-line income. Despite the significant operating losses, the company maintains a free cash flow of $93.85M, which suggests a unique financial flexibility potentially driven by non-operating cash sources or treasury holdings rather than core operational profitability. The gross margin stands at -202.5%, the operating margin at -6512.1%, and the profit margin at 0.0%, indicating that for every dollar of revenue generated, the company incurs costs well exceeding the sale price, leading to negative profitability across all margin levels. On the balance sheet, the company holds $10.38M in cash against $3.08M in debt, resulting in a debt-to-equity ratio of 1.17, which implies a leveraged position where debt obligations exceed equity capitalization. The current ratio of 4.02 indicates that the company possesses $4.02 in current assets for every $1.00 of current liabilities, suggesting a strong short-term liquidity position capable of meeting its near-term obligations. Return on Equity is reported at -203.0% and Return on Assets at -6.0%, revealing that management has generated negative returns on both shareholder equity and total assets during the period, reflecting challenges in utilizing the company's capital base effectively to generate profit.

मूल्यांकन आकलन

The trailing P/E ratio and forward P/E ratio are both listed as N/A, meaning that traditional earnings-based valuation multiples cannot be calculated due to the absence of positive earnings, which implies that standard earnings trajectory comparisons are currently inapplicable for this stock. The price-to-book ratio is reported as 0.00, indicating that the market capitalization is either zero or negligible relative to the company's book value, suggesting no traditional market premium over book value exists in the current trading environment. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are also listed as N/A, which prevents the use of revenue or enterprise value based multiples to assess the company's relative value against peers. The 52-week high is $0.04 and the 52-week low is $0.03, and based on the price-to-book ratio of 0.00, the current trading price effectively sits at or below the 52-week low, reflecting a market valuation that is minimal relative to the instrument's recent price range. The beta value is 2.07, which indicates that the stock price is expected to be twice as volatile as the broader market, meaning that price fluctuations in the general market will likely result in significantly larger swings in the Sharps Technology, Inc. share price.

Growth & Income

The revenue growth year-over-year and earnings growth year-over-year are both listed as N/A, preventing a direct comparison of whether earnings are growing faster or slower than revenue due to the lack of historical growth data in the provided facts. Since the company does not pay dividends, as evidenced by the N/A dividend yield and payout ratio, the company retains earnings or other capital to reinvest into growth initiatives rather than distributing income to shareholders. The absence of dividend payments combined with negative net income suggests that the company is not generating distributable cash flow from operations, relying instead on other financial mechanisms to sustain its operations. Overall, the growth and income profile of Sharps Technology, Inc. is characterized by a lack of historical growth data, a complete absence of dividend income, and a reliance on non-operational cash flows to offset significant operational losses.